Valuation
- Market cap
- 23,585,000
- Revenue TTM
- $0
- Net income TTM
- $-11,720,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 54,600
- Avg volume
- 48,006
- Day's range
- $4.48 – $5.15
- Shares out
- 4,765,000
- Stochastic %K
- 80%
- Beta
- -0.04
- Analysts
- —
- Price target
- —
Company profile
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 240 403 4212
- Website
- https://www.shuttlepharma.com
- Address
- 401 Professional Drive, Suite 260, Gaithersburg, United States
Latest news
No headlines yet.
